Macralytics CMS

Measure Type: Process

Screening for Osteoporosis for Women Aged 65-85 Years of Age

June 11, 2026
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care

June 11, 2026
Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older

June 11, 2026
Anti-Depressant Medication Management

June 11, 2026
Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation

June 11, 2026
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

June 11, 2026
Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)

June 11, 2026
Coronary Artery Disease (CAD): Antiplatelet Therapy

June 11, 2026
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

June 11, 2026